JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
88 hedge funds and large institutions have $125M invested in Jounce Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 26 closing their positions.
Holders
88
Holders Change
-12
Holders Change %
-12%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
38
Reduced
20
Closed
26
Calls
$448K
Puts
$216K
Net Calls
+$232K
Net Calls Change
+$195K
